Medication info
Telmisartan Amlodipine Tabs 80/5mg

Telmisartan Amlodipine Tabs 80/5mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
White Life Sciences Co., Ltd.
Appearance
White or whitish rectangular tablet
Packaging
30 tablets (10 tablets/Alu-Alu x 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201706642 · Approved 2017.08.17 · Insurance code 625201800

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan must not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
Pediatric patients aged 18 years or younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
White Life Sciences Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential Hypertension
View approved original text

This medication is used for patients with essential hypertension who find it difficult to control blood pressure with monotherapy using Amlodipine or Telmisartan alone. Essential hypertension refers to high blood pressure that occurs without a specific cause, and it is crucial to manage blood pressure stably for heart and vascular health. This medication effectively lowers blood pressure, reduces the risk of cardiovascular complications, and helps improve overall blood pressure control. Therefore, patients can manage their blood pressure better by taking this medicine.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan must not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

Pediatric patients aged 18 years or younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication may cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, therefore it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to individuals allergic to active ingredients or similar substances, nursing mothers, and patients with severe liver or heart issues. Patients with compromised liver function, gastrointestinal conditions, decreased kidney function, elderly individuals, etc., should exercise caution when using this medication and must follow their physician's directions. Taking this medication may cause side effects such as dizziness or swelling, and in severe cases, fainting or heart problems may occur. Immediate consultation with medical personnel is advised if unusual symptoms occur. Symptoms of hypotension may occur if blood pressure drops too low, especially in patients with dehydration; therefore, consultation with a physician before taking should be done, and careful monitoring is required. This medication may interact with others; if taking other medications, always inform a doctor or pharmacist, particularly when taken with drugs that increase potassium levels, as regular monitoring of serum potassium levels is necessary. Pregnant women or those planning to become pregnant are recommended to use other antihypertensive medications proven to be safe instead and should discontinue use immediately if pregnancy is confirmed. It is preferable that nursing mothers do not take this medication and consult with their physician to find alternative treatments if necessary. Care should be taken while driving or operating machinery as dizziness or drowsiness may occur. In cases of overdose, severe hypotension or cardiac side effects may occur. It is crucial to adhere to the prescribed dose, and in the case of overdose, immediate contact with a healthcare facility is necessary. This medication should be kept out of reach of children, and it is advisable to open the package just before taking the product.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disturbances
  • tremor
  • extrapyramidal disorders
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic epidermal necrolysis
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • kidney dysfunction
  • acute renal failure
  • urination disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a light-blocking container. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication and ensures safe usage.

Appearance and packaging

Appearance

White or whitish rectangular tablet

Package unit

30 tablets (10 tablets/Alu-Alu x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.